No |
Oral Sites
(ICD-10) |
Control group |
Precancerous |
Cancerous |
Grand Total |
Leukoplakia |
Erythroplakia |
Benign |
Malignant |
Male |
Female |
Male |
Female |
Male |
Female |
Male |
Female |
Male |
Female |
1 |
Lip |
5(6.1) |
6(11.1) |
2(13.3) |
2(14.3) |
1(5.9) |
2(22.2) |
2(5.7) |
1(5.0) |
Nil |
1(9.1) |
22(8.8) |
2 |
Tongue |
11(13.4) |
7 (12.97) |
4(26.7) |
2(14.3) |
3(17.6) |
1(11.1) |
2(5.7) |
2(10.0) |
2(13.3) |
2(18.2) |
36(13.2) |
3 |
Alveolus and gingiva |
16(19.5) |
6(11.1) |
3(20.0) |
2(14.3) |
2(11.8) |
2(22.2) |
8(22.9) |
1(5.0) |
3(20.0) |
1(9.1) |
44(17.6) |
4 |
Floor of the mouth |
7(8.5) |
6(11.1) |
2(13.3) |
3(21.4) |
1(5.9) |
1(11.1) |
3(8.60) |
2(10.0) |
1(6.7) |
Nil |
26(9.5) |
5 |
Palate |
6(7.3) |
3(5.6) |
Nil |
Nil |
3(17.6) |
1(11.1) |
2(5.7) |
2(10.0) |
1(6.7) |
Nil |
18(6.5) |
6 |
Buccal mucosa |
37(45.2) |
26(48.2) |
4(26.7) |
5(35.7) |
7(41.2) |
2(22.2) |
18(51.4) |
12(60.0) |
8(53.3) |
7(63.6) |
126(46.4) |
Total |
82 |
54 |
15 |
14 |
17 |
09 |
35 |
20 |
15 |
11 |
272 |
|